Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Schizophrenia Research|December 16, 2018
Off-hours use of a smartphone intervention to extend support for individuals with schizophrenia spectrum disorders recently discharged from a psychiatric hospitalEric D Achtyes, Dror Ben-Zeev, Zhehui Luo, et al.
JMIR Mental Health|July 29, 2016
mHealth for Schizophrenia: Patient Engagement With a Mobile Phone Intervention Following Hospital DischargeDror Ben-Zeev, Emily A Scherer, Jennifer D Gottlieb, et al.
JAMA Psychiatry|October 17, 2014
Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP studyChristoph U Correll, Delbert G Robinson, Nina R Schooler, et al.
Psychiatric Services (Washington, D.C.)|January 16, 2015
Duration of Untreated Psychosis in Community Treatment Settings in the United StatesJean Addington, Robert K Heinssen, Delbert G Robinson, et al.
The American Journal of Psychiatry|March 3, 2015
Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP studyDelbert G Robinson, Nina R Schooler, Majnu John, et al.
BMJ Open Respiratory Research|February 7, 2023
Association between tobacco product use and asthma among US adults from the Population Assessment of Tobacco and Health (PATH) Study waves 2-4Mary F Brunette, Michael J Halenar, Kathryn C Edwards, et al.
Schizophrenia Research|July 13, 2017
Demographic and clinical correlates of substance use disorders in first episode psychosisMary F Brunette, Kim T Mueser, Steven Babbin, et al.
Schizophrenia Bulletin|February 3, 2016
Cost-Effectiveness of Comprehensive, Integrated Care for First Episode Psychosis in the NIMH RAISE Early Treatment ProgramRobert Rosenheck, Douglas Leslie, Kyaw Sint, et al.
Psychiatric Services (Washington, D.C.)|March 17, 2015
The NAVIGATE Program for First-Episode Psychosis: Rationale, Overview, and Description of Psychosocial ComponentsKim T Mueser, David L Penn, Jean Addington, et al.
Alcoholism, Clinical and Experimental Research|September 29, 2011
A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patientsRaye Z Litten, Joanne B Fertig, Daniel E Falk, et al.
Pageof 14